re: skint/refresher 4-6 weeks to USA listing is good . At least in the USA there are drugs to compare with Coramsine . To get a partial response in 16% of patients against mixed refractory tumours is unusual . To find the ones that compare in their first phase 1 against solid mixed tumours is easy . Just research all the blockbusters .
Cheers
- Forums
- ASX - By Stock
- SBP
- genentech up $11 billion
SBP
solbec pharmaceuticals limited
genentech up $11 billion, page-15
Featured News
NEWS
Antler Copper Project hits major permitting milestone – air quality permit advances to final review